Welcome to IAM Patent 1000 2017 – The World’s Leading Patent Professionals, the sixth edition of IAM’s market-leading guide that identifies and profiles leading private practice patent professionals and firms in the world’s key jurisdictions, as well as expert witnesses in the United States.
This issue of the IAM Patent 1000 is the biggest ever and covers more jurisdictions in greater depth than any other publication available anywhere in the world. It is unique as a one-stop resource that focuses exclusively on naming best-in-class patent prosecution, licensing and litigation practitioners on a global basis, alongside US expert witnesses.
Over a five-month period, thousands of private practice lawyers and attorneys based in dozens of countries, as well as the users of their services, shared their thoughts on the market with our dedicated research team working out of offices in London and Hong Kong. These detailed, confidential interviews were a crucial part of the process to identify the practitioners and practices that are considered to excel at providing patent-related legal services. On top of this, in the United States we also asked interviewees to name the expert witnesses whom they turn to when they need world-class input on both damages and technical issues. In all cases the feedback we received was coupled with written submissions and additional investigations so that a full assessment of all potential candidates for inclusion could be made.
All those who make the final listings in the IAM Patent 1000 are included because we have received substantial positive feedback about them from multiple sources. We do not claim to have found every top name in every jurisdiction covered; but we are confident that the men and women included within these pages make up the vast majority, and that everybody named fully deserves the recognition. For a detailed methodology that explains the research process, as well as how the research team decides who should finally be listed, please click here.
In addition to the listings and editorial, you will find further biographical information on some of the individuals featured at the end of each country section, and on some of the selected firms at the end of each regional chapter. Everyone selected for inclusion in the IAM Patent 1000 is offered the opportunity to publish this information for a fee – some choose to do so, others do not. Either way, it has no effect on listing or ranking decisions; research is always conducted entirely independently of any commercial considerations.
Search IAM Patent 1000
Bhering Advogados is a law firm founded in 1978 with headquarters in Rio de Janeiro and offices in Sao Paulo and Curitiba. It specialises in intellectual property, including trademarks, patents, industrial design, copyright and neighbouring rights, IT law, enforcement against counterfeiting, unfair competition, licensing, transfer of technology and IP litigation. We consider the identification and management of intellectual assets important in achieving strategic goals, so we maintain a consistent connection between legal knowledge and the understanding of advances in science and technology. With decades of expertise, Bhering Advogados is capable of providing specialised ...
Managing Director -
Michael J Dansky, managing director and national leader in charge of BRG-Capstone’s IP services practice, has more than 30 years’ experience in IP strategy, valuation and transactions which have arisen from dispute resolution. He has assessed, valued, commercialised, licensed and sold IP portfolios in a wide range of industries and in many technical disciplines. As an expert in IP litigation matters during his 30-plus-year career, he has significant experience with patents, copyright, know-how and trade secrets, as well as accounting, finance and transaction-related matters. He has testified in state, federal and bankruptcy courts, before federal administrative agencies and in ...
The Argentine patent market has been beset by numerous challenges in recent years. Joint resolutions introduced in 2012 limited the patentability of inventions in the pharmaceutical and biotechnology spheres. The more recent Joint Resolution 283/2015 has further inhibited the scope of protection that can be afforded to inventions. Persistent economic woes and a large backlog of cases at the National Institute of Industrial Property (INPI) have not helped matters. However, far from a feeling of doom and gloom, optimism abounds. Since taking power at the end of 2015, the current government has been focusing on attracting foreign investors and new businesses to reinvigorate the ...
Register for more free content
- Read more IAM blogs and articles
- Receive the editor's weekly review by email